The European neurovascular device market will grow strongly through 2027, fueled by rapid expansion of the neurovascular thrombectomy device market and by the uptake of newer neurovascular intervention technologies.

This Medtech 360 Report provides high-level market metrics for neurovascular devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents

  • Neurovascular Devices - Market Insights - Europe (Supplemental)

Author(s): Shruthi Narendranath, MSc

Shruthi Narendranath is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in heart valve and periphral vascular device markets. Shruthi holds a Master's degree in Bioinformatics from Cardiff University.


Related Reports

Heart Valve Devices - Market Insights - Latin America

The Latin American heart valve device market will experience strong growth through 2029, largely driven by an expanding patient pool, improving...

View Details

Dialysis Access Treatment Devices - Market Insights - Europe

The European market for dialysis access treatment devices is a dynamic market that will grow moderately through 2029, driven by the availability of novel and innovative products. However, market re...

View Details

Dialysis Access Treatment Devices - Market Insights - Asia Pacific

The Asia Pacific dialysis access treatment device market will grow modestly through 2029, driven by rising incidence of

View Details

Cardiac Rhythm Management Devices - Market Insights - Japan

The mature Japanese CRM device market will remain flat through 2029, characterized by low generator unit volume growth, rising

View Details